CVS Health upgraded at TD Cowen after insurer unveils 2025 Medicare Advantage plan
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Bernstein SocGen Group Upgrades Humana (HUM) to Outperform
October 8, 2024 5:50 AM EDTBernstein SocGen Group analyst Lance Wilkes upgraded Humana (NYSE: HUM) from Market Perform to Outperform with a price target of $308.00 (from $405.00).
The analyst comments "We are updating our model, decreasing our target price, but upgrading our rating to Outperform based on a view that risks are being incorporated into expectations and price, coupled with improving sector outlook and potential upside catalysts. Upgrading HUM, our investment thesis - We believe HUM is now an attractive... More
TD Cowen Downgrades Humana (HUM) to Hold
October 7, 2024 5:29 AM EDTTD Cowen analyst Gary Taylor downgraded Humana (NYSE: HUM) from Buy to Hold with a price target of $261.00 (from $402.00).
The analyst comments "We are downgrading Humana from a Buy to Hold rating. Despite MA plans' ability to reprice the business each year (and... More
